TREA

85583401 - BIAL

Follow

Information

  • Trademark
  • 85583401
  • Serial Number
    85583401
  • Registration Number
    4490162
  • Filing Date
    March 29, 2012
    12 years ago
  • Registration Date
    March 04, 2014
    10 years ago
  • Transaction Date
    November 17, 2020
    4 years ago
  • Status Date
    October 09, 2020
    4 years ago
  • Published for Opposition Date
    March 19, 2013
    11 years ago
  • Location Date
    March 04, 2014
    10 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GAYNOR, BARBARA ANNE
  • Attorney Docket Number
    CRUZ/8239
    Attorney Name
    James L. Bikoff
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
BIAL
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of the stylized letters "BIAL".
  • GS0051: Pharmaceutical preparations for the treatment of cardiovascular diseases, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations; pharmaceutical preparations, namely, decongestants and anti-histamines; pharmaceutical preparations for the treatment of pains, cough, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; pharmaceuticals for the treatment of pain, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations for the prevention and treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and treatment of tumours of any description; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, bipolar disorder, neuropathic pain, migraine, generalized anxiety disorder, social phobia, diabetic neuropathies, panic disorder, postoperative pain, back pain, fibromyalgia, and postherpetic neuralgia, post-traumatic stress disorder, Parkinson's disease, Alzheimers; pharmaceutical preparations for the treatment of psychiatric diseases, namely, schizophrenia, anxiety disorders, mood disorders, cognitive disorders, depression, mania; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for treatment of gout, namely, broncho-dilators and anti-asthmatic preparations; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances, namely, antibiotics, antivirals, antidiabetic preparations, nondepolarizing skeletal neuromuscular blocking agents, hemostatic agents, expectorants, anti-leukemia agents, anti-arrhythmics, dermatologicals and vasopressors; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, and spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations, namely, muscle relaxants and anti-emetics, xanthine oxidase inhibitors; pharmaceutical preparations, namely, scabicides, anti-malarials
  • GS0421: Pharmaceutical, medical and biological research and development in the field of human therapeutics; conducting of pre-clinical and clinical test research in the pharmaceutical and medical fields; scientific research and development in the field of human medicine
Case File Event Statements
  • 10/9/2020 - 4 years ago
    25 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 3/4/2019 - 5 years ago
    24 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 1/15/2015 - 10 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/4/2014 - 10 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/28/2014 - 11 years ago
    21 - PAPER RECEIVED Type: MAIL
  • 1/28/2014 - 11 years ago
    20 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 1/28/2014 - 11 years ago
    19 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 1/28/2014 - 11 years ago
    18 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 7/16/2013 - 11 years ago
    17 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 4/16/2013 - 11 years ago
    16 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 3/19/2013 - 11 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/19/2013 - 11 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/27/2013 - 12 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/11/2013 - 12 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/11/2013 - 12 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 1/31/2013 - 12 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/11/2013 - 12 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/11/2013 - 12 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/11/2013 - 12 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/11/2012 - 12 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/11/2012 - 12 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/11/2012 - 12 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/10/2012 - 12 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/4/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/2/2012 - 12 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP